rs56010818
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000104.4(CYP1B1):c.1169G>A(p.Arg390His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R390S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000104.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP1B1 | NM_000104.4 | c.1169G>A | p.Arg390His | missense_variant | 3/3 | ENST00000610745.5 | NP_000095.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP1B1 | ENST00000610745.5 | c.1169G>A | p.Arg390His | missense_variant | 3/3 | 1 | NM_000104.4 | ENSP00000478561.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000921 AC: 23AN: 249616Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135260
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461496Hom.: 0 Cov.: 35 AF XY: 0.0000413 AC XY: 30AN XY: 727062
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74314
ClinVar
Submissions by phenotype
Anterior segment dysgenesis 6 Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 26, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Sep 02, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics | Nov 16, 2023 | A homozygous missense variant in exon 3 of the CYP1B1 gene that results in the amino acid substitution of Histidine for Arginine at codon 390 (p.Arg390His) was detected. The observed variant has previously been reported in patients affected with congenital glaucoma [PMID: 9497261]. This variant has not been reported in the 1000 genomes databases and has a minor allele frequency of 0.006%, 0.009% and 0.004% in the gnomAD (v3.1), gnomdAD (v2.1) and topmed databases respectively. The in-silico prediction of the variant are probably damaging by PolyPhen-2 (HumDiv), damaging by SIFT and LRT. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as likely pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Pediatrics Genetics, Post Graduate Institute of Medical Education and Research | Aug 31, 2023 | This variant is not present in gnomad. PM1+PM2+PP3+PP5 - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 03, 2018 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | May 03, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 26, 2022 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 30820150, 25527694, 27508083, 19536304, 31236345, 29903728, 22878448, 19204079, 30108387, 30270463, 29540704, 34019190, 32830442, 19247456, 9497261, 25018621, 15475877) - |
Glaucoma 3A Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | May 20, 2023 | The observed missense c.1169G>A(p.Arg390His) variant in CYP1B1 gene has been reported in homozygous or compound heterozygous state in individuals affected with primary congenital glaucoma (Rauf B, et. al., 2016; Su CC, et. al., 2012). This variant is present with an allele frequency of 0.009% in gnomAD Exomes database. This variant has been submitted to the ClinVar database as Likely pathogenic/Pathogenic (multiple submissions). Multiple lines of computational evidence ( SIFT - damaging and MutationTaster - disease causing) predict a damaging effect on protein structure and function for this variant. The amino acid change p.Arg390His in CYP1B1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Arg at position 390 is changed to a His changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | research | Institute of Basic Medical Sciences, Khyber Medical University, Peshawar | Dec 06, 2023 | This variant is classified as pathogenic and its already reported. The pubmed link for this article via PMID is 9497261 - |
Primary congenital glaucoma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 29, 2024 | Variant summary: CYP1B1 c.1169G>A (p.Arg390His) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 9.2e-05 in 249616 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in CYP1B1 causing Primary Congenital Glaucoma (9.2e-05 vs 0.0043), allowing no conclusion about variant significance. c.1169G>A has been reported in the literature as a biallelic genotype in many individuals affected with Primary Congenital Glaucoma and has been found to segregate with disease in multiple families (e.g. Sheikh_2014, Chitsazian_2007). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 17591938, 25018621). ClinVar contains an entry for this variant (Variation ID: 592512). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Congenital glaucoma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 390 of the CYP1B1 protein (p.Arg390His). This variant is present in population databases (rs56010818, gnomAD 0.06%). This missense change has been observed in individual(s) with primary congenital glaucoma (PMID: 19536304, 27508083, 30108387). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 592512). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CYP1B1 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg390 amino acid residue in CYP1B1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15037581, 20664688; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at